LIM-domain-only 4 (LMO4) Enhances CD8+ T-cell Stemness and Tumor Rejection by Boosting IL-21-STAT3 Signaling.
Roland C. Schelker,Jessica Fioravanti, Fabio Mastrogiovanni,Jeremy G. Baldwin, Nisha Rana,Peng Li, Ping Chen, Timea Vadasz,Rosanne Spolski,Christoph Heuser-Loy,Dragana Slavkovic-Lukic, Pedro Noronha,Giuseppe Damiano,Laura Raccosta,Daniela Maggioni, Sree Pullugula,Jian-Xin Lin,Jangsuk Oh, Patrick Grandinetti, Mario Lecce, Leo Hesse, Emilia Kocks, Azucena Martin-Santos,Claudia Gebhard,William G. Telford,Yun Ji,Nicholas P. Restifo,Vincenzo Russo,Michael Rehli,Wolfgang Herr,Warren J. Leonard,Luca Gattinoni Signal Transduction and Targeted Therapy（2024）
AI 理解论文
溯源树
样例
